Vasostrict
NDC Package 42023-220-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vasostrict is ® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. Marketed by Par Health Usa, Llc, this product is identified by NDC 42023-220 and is authorized under FDA application NDA204485.

Identification & Billing

NDC Package Code
42023-220-10
Package Description
10 VIAL in 1 CARTON / 100 mL in 1 VIAL (42023-220-01)
Product Code
11-Digit Billing Format
42023022010
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vasostrict
Dosage Form
-
Usage Information
Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Regulatory & Marketing

Labeler Name
Par Health Usa, Llc
FDA Application #
NDA204485
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
12-15-2021
End Marketing Date
05-15-2026
Listing Expiration
05-15-2026
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42023-220-10 identifies a specific commercial package of 10 vial in 1 carton / 100 ml in 1 vial (42023-220-01) of Vasostrict, labeled by Par Health Usa, Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Par Health Usa, Llc on December 15, 2021. The current certification is valid through May 15, 2026.

How is this Par Health Usa, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42023022010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
42023-220-10
11-Digit CMS (5-4-2)
42023-0220-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.